00:00 / 00:00
Vitamin K plays a crucial role in blood coagulation, which is the process by which the body forms clots to stop bleeding. Vitamin K acts as a cofactor for a group of proteins known as the vitamin K-dependent clotting factors (II, VII, IX, and X ), which are involved in the activation of blood-clotting proteins. To be useful, vitamin K undergoes a series of oxidation and reduction reactions called the vitamin K cycle.
Vitamin K deficiency can result in impaired blood clotting, leading to spontaneous bleeding or excessive bleeding from cuts or injuries. Newborn infants are at particular risk because they have limited stores of vitamin K, and are often not able to produce enough of the vitamin on their own. This is why they are typically given a single injection of vitamin K shortly after birth.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.